SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16490869
Source:
http://linkedlifedata.com/resource/pubmed/id/16490869
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0205171
,
umls-concept:C0206717
,
umls-concept:C0549178
,
umls-concept:C0596545
,
umls-concept:C1522577
,
umls-concept:C2607850
pubmed:issue
2
pubmed:dateCreated
2006-2-21
pubmed:abstractText
To analyze outcomes and to provide follow-up for our increasing patient cohort with esthesioneuroblastoma.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8603209
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin
,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0886-4470
pubmed:author
pubmed-author:JaneJohn AJA
,
pubmed-author:LevinePaul APA
,
pubmed-author:LoyAndrew HAH
,
pubmed-author:NewmanSteven ASA
,
pubmed-author:ReadPaul WPW
,
pubmed-author:ReibelJames FJF
,
pubmed-author:ThomasChristopher YCY
pubmed:issnType
Print
pubmed:volume
132
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
134-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16490869-Adolescent
,
pubmed-meshheading:16490869-Adult
,
pubmed-meshheading:16490869-Aged
,
pubmed-meshheading:16490869-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:16490869-Child
,
pubmed-meshheading:16490869-Cyclophosphamide
,
pubmed-meshheading:16490869-Doxorubicin
,
pubmed-meshheading:16490869-Esthesioneuroblastoma, Olfactory
,
pubmed-meshheading:16490869-Female
,
pubmed-meshheading:16490869-Follow-Up Studies
,
pubmed-meshheading:16490869-Humans
,
pubmed-meshheading:16490869-Male
,
pubmed-meshheading:16490869-Middle Aged
,
pubmed-meshheading:16490869-Nasal Cavity
,
pubmed-meshheading:16490869-Neoplasm Recurrence, Local
,
pubmed-meshheading:16490869-Neurosurgical Procedures
,
pubmed-meshheading:16490869-Nose Neoplasms
,
pubmed-meshheading:16490869-Radiotherapy, Adjuvant
,
pubmed-meshheading:16490869-Retrospective Studies
,
pubmed-meshheading:16490869-Treatment Outcome
,
pubmed-meshheading:16490869-Vincristine
pubmed:year
2006
pubmed:articleTitle
Esthesioneuroblastoma: continued follow-up of a single institution's experience.
pubmed:affiliation
Department of Otolaryngology-Head and Neck Surgery, University of Virginia Health System, Charlottesville 22908-0713, USA.
pubmed:publicationType
Journal Article
,
Comparative Study